Predicting clinical instability of older patients in post-acute care units: a nationwide cohort study

Wei-Ju Lee1, Ming-Yueh Chou, Li-Ning Peng

  • 1Division of Geriatric Medicine, Taipei Veterans General Hospital Yuanshan Branch, I-Lan, Taiwan; Aging and Health Research Center, National Yang Ming University, Taipei, Taiwan.

Insights

Approximately 13% of post-acute care (PAC) patients experience readmission due to medical issues. Poor cognitive function is a key predictor of clinical instability in PAC settings, requiring increased attention.

Area of Science:

  • Geriatric Medicine
  • Health Services Research
  • Clinical Outcomes

Background:

  • Post-acute care (PAC) patients are typically stable, but unexpected medical events can lead to acute ward readmissions.
  • These readmissions can negatively impact the effectiveness of PAC services.

Purpose of the Study:

  • To identify predictive factors for clinical instability in PAC patients.
  • To enhance the quality of PAC services by understanding readmission triggers.

Main Methods:

  • A nationwide multicenter cohort study involving 918 patients from five PAC units in Taiwan.
  • Comprehensive Geriatric Assessment (CGA) administered within 72 hours of admission.
  • Clinical instability defined as conditions requiring acute ward readmission.

Main Results:

  • 12.9% of patients were readmitted, primarily for medical conditions (89.1%).
  • Readmitted patients exhibited poorer functional status, cognitive function (lower Mini-Mental State Examination scores), and nutritional status.
  • Lower Mini-Mental State Examination scores were the sole independent predictor of clinical instability (OR 3.8, P=0.012).

Conclusions:

  • About 13% of PAC patients face readmission, predominantly due to medical causes.
  • Impaired cognitive function is a significant predictor of clinical instability in PAC.
  • Increased clinical focus on cognitive status is recommended for all PAC patients.
Abstract

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...